Viking Stock Rises 29% in Three Months: Time to Buy, Hold or Sell?

Shares of Viking Therapeutics (VKTX) have risen 29% in the past three months, significantly outperforming the industry's 2.5% growth. The stock has outperformed the sector and the S&P 500 during the same period. VKTX's shares are also trading above the 50-day and 200-day moving averages. VKTX Stock Outperforms Industry, Sector & S&P 500 Zacks Investment Research Image Source: This uptick in stock price was triggered by positive updates from Viking's pipeline programs. Last week, VKTX reported positive resul ...